This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Notice
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
Endocrine Disruptor Method Validation Subcommittee Under the National Advisory Council for Environmental Policy and Technology; Notice of Public Meeting
The 2-day meeting will be held on October 30, 2001, from 9 a.m. to 5:15 p.m. and October 31, 2001, from 9 a.m. to 12:30 p.m. Requests to participate in the meeting must be received on or before October 26, 2001.
Table of Contents
Enhanced Content - Table of Contents
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
13
as of
09/06/2026 at 6:15 pm EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Environmental Protection Agency (EPA).
ACTION:
Notice.
SUMMARY:
As mandated by the Federal Food, Drug, and Cosmetic Act, as amended by the Food Quality Protection Act of 1996, EPA is implementing an Endocrine Disruptor Screening Program (EDSP). As part of the implementation of EDSP, the Endocrine Disruptor Method Validation Subcommittee (EDMVS) under the National Advisory Council for Environmental Policy and Technology (NACEPT), a Federal Advisory Committee, has been established. This notice announces a 2-day meeting of the EDMVS. EDMVS will provide technical advice on the Tier 1 Screening and Tier 2 Testing methods for EPA's EDSP. The meeting is open to the public. Seating is on a first-come basis. Individuals requiring special accommodations at this meeting, including wheelchair access, should contact Jane Smith at the address listed under
FOR FURTHER INFORMATION CONTACT
at least 5 business days prior to the meeting, so appropriate arrangements can be made.
DATES:
The 2-day meeting will be held on October 30, 2001, from 9 a.m. to 5:15 p.m. and October 31, 2001, from 9 a.m. to 12:30 p.m. Requests to participate in the meeting must be received on or before October 26, 2001.
ADDRESSES:
The meeting will be held at the Hilton Washington Dulles Airport, 13869 Park Center Road, Herndon, VA 20171. The telephone number at the Hilton Washington is (703) 478-2900; the fax number is (703) 478-9286.
Requests to participate may be submitted by mail, electronically, or in person. Please follow the detailed instructions for each method as provided in Unit II. of the
SUPPLEMENTARY INFORMATION
. To ensure proper receipt by EPA, your request must identify docket control number OPPT-42212D in the subject line on the first page of your response.
FOR FURTHER INFORMATION CONTACT:
Jane Smith, Designated Federal Official, Office of Science Coordination and Policy (7203), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460; telephone number: (202) 260-1597; fax number: (202) 401-1282; e-mail address: smith.jane-scott&epa.gov.
SUPPLEMENTARY INFORMATION:
I. Does This Action Apply to Me?
This action is directed to the public in general. This action may, however, be of interest if you produce, manufacture, use, consume, work with, or import pesticide chemicals, substances that may have an effect cumulative to an effect of a pesticide, or substances found in sources of drinking water. To determine whether you or your business may have an interest in this notice you should carefully examine section 408(p) of the Federal Food, Drug, and Cosmetic
( printed page 51952)
Act (FFDCA), as amended by the Food Quality Protection Act of 1996 (Public Law 104-170), 21 U.S.C. 346a (p) and amendments to the Safe Drinking Water Act (Public Law 104-182), 42 U.S.C. 300j-17. Since other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under
FOR FURTHER INFORMATION CONTACT
.
II. How Can I Get Additional Information, Including Copies of This Document and Other Related Documents?
1.
Electronically. A list of EDMVS members and the meeting agenda are now available. In addition, the Agency may provide additional background documents as the material becomes available. You may obtain electronic copies of these documents, and other related documents that may be available electronically, from the EPA Internet Home Page at http://www.epa.gov/scipoly/oscpendo. To access this document, on the Home Page select “Endocrine Disruptors” which will take you to the OSCP Endocrine Disruptor Screening Program web site. You can also go directly to the “
Federal Register
” listings at http://www.epa.gov/fedrgstr/.
2.
In person. The Agency has established an administrative record for this meeting under docket control number OPPT-42212D. The administrative record consists of the documents specifically referenced in this notice, any public comments received during an applicable comment period, and other information related to Endocrine Disruptor Method Validation, including any information claimed as Confidential Business Information (CBI). This administrative record includes the documents that are physically located in the docket, as well as the documents that are referenced in those documents. The public version of the administrative record, which includes printed, paper versions of any electronic comments that may be submitted during an applicable comment period, is available for inspection in the TSCA Nonconfidential Information Center, North East Mall Rm. B-607, Waterside Mall, 401 M St., SW., Washington, DC. The Center is open from noon to 4 p.m., Monday through Friday, excluding legal holidays. The telephone number of the Center is (202) 260-7099.
III. How Can I Request to Participate in this Meeting?
You may submit a request to participate in this meeting through the mail, in person, or electronically. Do not submit any information in your request that is considered CBI. Your request must be received by EPA on or before October 26, 2001. To ensure proper receipt by EPA, it is imperative that you identify docket control number OPPT-42212D in the subject line on the first page of your request.
1.
By mail. You may submit a request to: Docket Control Office (7407), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460.
2.
In person or by courier. You may deliver a request to: OPPT Docket Control Office, North East Mall Rm. B-607, Waterside Mall, 401 M St., SW., Washington, DC. The Docket Control Office is open from 8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The telephone number of the Center is (202) 260-7099.
3.
Electronically. You may submit your request electronically by e-mail to: oppt-ncic@epa.gov. Do not submit any information electronically that you consider to be CBI. Use WordPerfect 6.1/8.0 or ASCII file format and avoid the use of special characters and any form of encryption. Be sure to identify by docket control number OPPT-42212D. You may also file a request online at many Federal Depository Libraries.
IV. Meeting Overview
October 30, 2001
Brief overview of NACEPT.
Overview of the endocrine program at EPA—Validation: Process, program status and timeline, roles and relationships and illustration-utertrophic assay, public comment.
October 31, 2001
EDMVS process.
Next steps.
List of Subjects
Environmental protection
Endocrine disruptors
Dated: October 4, 2001.
Vanessa Vu,
Director, Office of Science Coordination and Policy, Office of Prevention, Pesticides and Toxic Substances.